Atorolimumab Biosimilar - Research Grade

Human

RHDï؟½

5mg/ml

IgG3 - kappa

CHO Cells

https://www.imgt.org/mAb-DB/

ICH3002

Q02161

Blue ice

The RhD antigen (RHD) is a red-cell surface protein central to blood group serology and alloimmunization research in haematology. Offered as an unconjugated, non-therapeutic analog of atorolimumab, this research-grade anti-RhD recombinant monoclonal antibody is intended for research use only (RUO). It is manufactured to in vivo quality standards, formulated for low endotoxin, and supplied in scalable milligram (mg) to gram (g) quantities for high-throughput and heavy-usage laboratories. Typical uses include red-cell binding and agglutination assays, in vitro functional screening, and in vivo immunohaematology models requiring a consistent, reproducible reagent.

This monoclonal antibody was purified using Protein A

Sterile, preservative-free, solution in PBS. BSA and Azide free.

This biosimilar is stable when stored at 2-8°C. For longer term storage (> 3 months) it is recommended to store this antibody at -20°C or -70°C.

Functional Assays

This biosimilar is for research use only (RUO): it is not for diagnostic or therapeutic procedures and cannot be purchased by patients.

Products are for research use only. Not for use in diagnostic or therapeutic procedures.

3-4 weeks